15:58 May 29

Supriya Lifescience Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
968.70
+161.45 (+20.00%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Supriya Lifescience Ltd. Financials

Supriya Lifescience Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
968.70
+161.45 (+20.00%)
15:58 May 29
Quality
image/svg+xml

46/100
Medium Financial Strength

Valuation
image/svg+xml

30/100
Expensive Valuation

Technical

60/100
Technically Neutral

Strength

13

Weakness

1

Opportunity

1

Threats

0

17.45 %

ROE %

15.40 %

ROA %

25.98

EPS

148.81

BVPS

0.00 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales
530.05 460.94 570.37 696.48 827.88
Operating Expenses +
316.06 332.04 397.4 435.69 533.82
Raw Material
198.83 187.32 191.43 232.44 265.12
Increase Decrease in Cost
-3.02 -6.51 30.31 -21.26 -11.09
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
49.08 55.58 67.64 80.52 96.68
Miscellaneous Expenses
71.17 95.65 108.02 143.99 183.11
Operating Profit
213.99 128.9 172.97 260.79 294.06
Other Income
7.58 9.49 10.64 9.82 11.49
Depreciation
10.12 11.82 15.81 20.44 28.41
Interest
4.2 3.08 2.11 1.69 1.89
Profit before tax and exceptio..
207.24 123.49 165.69 248.48 275.24
Exceptional Items
0 0 0 0 -0.46
PBT
207.24 123.49 165.69 248.48 274.78
Provision for Taxation
55.44 33.63 46.58 60.52 65.66
Net Profit
151.81 89.86 119.11 187.96 209.12
NET Profit after MI
0 0 0 0 0
EPS
18.86 11.16 14.8 23.35 25.98
Operating Profit Margin (%)
40.37 27.96 30.33 37.44 35.52
Net Profit Margin (%)
28.64 19.49 20.88 26.99 25.26

Supriya Lifescience Ltd. Shareholding

All Data in Percentage (%)

Promoter - - - - -
FII - - - - -
Public - - - - -
MF - - - - -
Others
Shareholder Shares Holding %
Download Our App On: